CLSD - Clearside Biomedical says CEO Lasezkay sells 18K shares January, 22 2024 11:42 AM Clearside Biomedical Inc. 2024-01-22 11:42:05 ET More on Clearside Biomedical Clearside Biomedical reports progress in ODYSSEY Phase 2b trial of CLS-AX BioCryst, Clearside Biomedical in pact for diabetic eye disease For further details see: Clearside Biomedical says CEO Lasezkay sells 18K shares